Evidence map›Paper›PMID 33182398›Full record

ArticlePharmaceutics2020

A pH-Adjustable Tissue Clearing Solution That Preserves Lipid Ultrastructures: Suitable Tissue Clearing Method for DDS Evaluation.

Shintaro Fumoto, Eriko Kinoshita, Keisuke Ohta, Kei-Ichiro Nakamura, Tasuku Hirayama, Hideko Nagasawa, Die Hu, Kazuya Okami, Riku Kato, Shojiro Shimokawa and 6 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Shintaro FumotoGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.ORCID 0000-0002-2218-4547
Eriko KinoshitaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Keisuke OhtaDivision of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume 830-0011, Japan.
Kei-Ichiro NakamuraDivision of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume 830-0011, Japan.
Tasuku HirayamaLaboratory of Pharmaceutical & Medicinal Chemistry, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu 501-1196, Japan.
Hideko NagasawaLaboratory of Pharmaceutical & Medicinal Chemistry, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu 501-1196, Japan.ORCID 0000-0002-7662-0762
Die HuGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Kazuya OkamiGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Riku KatoGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Shojiro ShimokawaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Naho OhiraGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Koyo NishimuraGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Hirotaka MiyamotoGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.ORCID 0000-0002-1903-9541
Takashi TanakaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.ORCID 0000-0001-7762-7432
Shigeru KawakamiGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Koyo NishidaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.
Nagasaki University · JPGifu Pharmaceutical University · JPKurume University · JP

Funding

JSPS JP16H01431JSPS JP16H06280MEXT JPMXS0422500320the Canon Foundation Not applicable
6 · The paper itself

Abstract

Visualizing biological events and states to resolve biological questions is challenging. Tissue clearing permits three-dimensional multicolor imaging. Here, we describe a pH-adjustable tissue clearing solution, Seebest (SEE Biological Events and States in Tissues), which preserves lipid ultrastructures at an electron microscopy level. Adoption of polyethylenimine was required for a wide pH range adjustment of the tissue clearing solution. The combination of polyethylenimine and urea had a good tissue clearing ability for multiple tissues within several hours. Blood vessels stained with lipophilic carbocyanine dyes were deeply visible using the solution. Adjusting the pH of the solution was important to maximize the fluorescent intensity and suppress dye leakage during tissue clearing. The spatial distribution of doxorubicin and oxidative stress were observable using the solution. Moreover, spatial distribution of liposomes in the liver was visualized. Hence, the Seebest solution provides pH-adjustable, rapid, sufficient tissue clearing, while preserving lipid ultrastructures, which is suitable for drug delivery system evaluations.

Indexed as

adult animalbiological imaginggene deliveryliposomemicroscopythree-dimensional imagingtissue optical clearing

Identifiers

PMID33182398
PMCPMC7698078
OpenAlexW3103358747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.